Skip to main content
. Author manuscript; available in PMC: 2013 Nov 1.
Published in final edited form as: Gen Hosp Psychiatry. 2012 Sep 5;34(6):581–587. doi: 10.1016/j.genhosppsych.2012.06.018

Table 3.

Problems and concerns patients attribute to opioid use by average daily dose (weighted estimates)

Opioid Morphine Equivalent Daily Dose
1-19mg 20-49mg 50-119mg 120+mg p-value a
Psychosocial Problems
Loss of interest in activities, % 4.9 9.6 8.0 14.6 0.01
Trouble concentrating, % 6.5 15.6 17.2 24.0 0.04
Feeling slowed down, sluggish, % 14.8 15.7 18.0 25.1 0.03
Feeling depressed, anxious, % 4.0 7.8 8.2 15.1 0.0004
Interference with work, family social
activities, %
10.8 16.9 22.9 32.2 <.0001
Hard to think clearly, % 8.6 14.6 17.1 24.2 0.15
Less alert when driving or other
activity require vigilance, %
20.8 28.7 35.8 45.4 0.007
Control Concerns
Preoccupied with opioids, % 5.0 10.1 7.2 9.2 0.24
Concern about control over use, % 2.8 4.7 5.4 8.0 0.63
Need higher dose for same effect, % 19.5 24.8 34.6 41.5 <.0001
Worry about opioid dependence, % 17.2 30.1 37.4 46.8 <.0001
Want to stop or cut-down on opioids,
%
33.9 44.5 50.3 51.5 0.01
Opioids caused family problems, % 1.7 4.5 7.4 10.7 0.046
Family or friends thought might be
addicted to opioids, %
5.8 11.0 18.2 24.9 <.0001
a

p-value for opioid dose adjusted for health plan and opioid type.